RHPRG4 FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
Phase 1
Not yet recruiting
- Conditions
- Sjogren's Syndrome With Dry Eye
- Interventions
- Drug: rhPRG4 (450 µg/mL)Drug: Vehicle
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Lubris Bio Pty Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT06520202
RHPRG4 FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Lubris Bio Pty Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT06495307
© Copyright 2025. All Rights Reserved by MedPath